Company intelligence / Profile preview

Phasecraft

Bristol, United Kingdom

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Phasecraft develops ultra‑efficient, hardware‑agnostic quantum algorithms for current NISQ quantum computers, enabling practical simulations and optimisation tasks in materials science, energy networks, and biological/drug discovery research, but it does not itself run therapeutic clinical trials.[1][2][4]

Industry: Drug Discovery Services

Partnerships

Google[1][2][5]IBM[1][2][5]Quantinuum[1][2]QuEra[1][2][5]Rigetti[5]Johnson Matthey[1][2]Oxford PV[1][2][3][5]BT[1][2][5]UK National Energy System Operator (NESO) / National Grid-related operator[1][2][5]Roche (evaluation of near-term quantum technologies for protein structure prediction)[3]

Beyond the preview

Go deeper on Phasecraft.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phasecraft.

Explore the full profile